5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione

C38H41N5O6 — CID 134261799

IUPAC5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione
SMILESCc1c(C(=O)C(O)c2ccccc2)cccc1-c1cn(CC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)c(=O)n(C(C)C)c1=O
InChIInChI=1S/C38H41N5O6/c1-24(2)43-36(47)31(29-13-9-14-30(25(29)3)35(46)34(45)27-11-5-4-6-12-27)22-41(38(43)49)23-33(44)40-19-17-28(18-20-40)42-21-16-26-10-7-8-15-32(26)39-37(42)48/h4-15,22,24,28,34,45H,16-21,23H2,1-3H3,(H,39,48)
InChIKeyMBRLZVMGXLCNIQ-UHFFFAOYSA-N
MW663.78 g/mol
LogP4.56
Rot. Bonds8

About 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione

5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione (PubChem CID 134261799) has the molecular formula C38H41N5O6 and a molecular weight of 663.78 g/mol. Its IUPAC name is 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione.

Molecular Properties

Compound Name5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione
PubChem CID134261799
Molecular FormulaC38H41N5O6
Molecular Weight663.78 g/mol
Exact Mass663.31
IUPAC Name5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione
SMILESCc1c(C(=O)C(O)c2ccccc2)cccc1-c1cn(CC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)c(=O)n(C(C)C)c1=O
InChIInChI=1S/C38H41N5O6/c1-24(2)43-36(47)31(29-13-9-14-30(25(29)3)35(46)34(45)27-11-5-4-6-12-27)22-41(38(43)49)23-33(44)40-19-17-28(18-20-40)42-21-16-26-10-7-8-15-32(26)39-37(42)48/h4-15,22,24,28,34,45H,16-21,23H2,1-3H3,(H,39,48)
InChIKeyMBRLZVMGXLCNIQ-UHFFFAOYSA-N
XLogP4.56
TPSA133.95 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds8
Heavy Atoms49
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500663.78
LogP ≤ 54.56
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione?
The IUPAC name of 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione (CID 134261799) is 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione.
What is the SMILES notation for 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione?
The canonical SMILES for 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione is Cc1c(C(=O)C(O)c2ccccc2)cccc1-c1cn(CC(=O)N2CCC(N3CCc4ccccc4NC3=O)CC2)c(=O)n(C(C)C)c1=O.
What is the InChIKey of 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione?
The InChIKey is MBRLZVMGXLCNIQ-UHFFFAOYSA-N. The full InChI is InChI=1S/C38H41N5O6/c1-24(2)43-36(47)31(29-13-9-14-30(25(29)3)35(46)34(45)27-11-5-4-6-12-27)22-41(38(43)49)23-33(44)40-19-17-28(18-20-40)42-21-16-26-10-7-8-15-32(26)39-37(42)48/h4-15,22,24,28,34,45H,16-21,23H2,1-3H3,(H,39,48).
What are the key properties of 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione?
5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione has a molecular weight of 663.78 g/mol, XLogP of 4.56, 8 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[3-(2-hydroxy-2-phenylacetyl)-2-methylphenyl]-1-[2-oxo-2-[4-(2-oxo-4,5-dihydro-1H-1,3-benzodiazepin-3-yl)piperidin-1-yl]ethyl]-3-propan-2-ylpyrimidine-2,4-dione is sourced from PubChem (CID 134261799), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).